EGFR and non-small cell lung carcinoma: In this study, we found that EGCG and GTE inhibited both IFN-γ– and EGF-induced PD-L1 expression by inhibiting two signaling pathways, JAK2/STAT1 and EGFR/Akt, in human NSCLC cell lines.